Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells

Autor: André O. von Bueren, Tarek Shalaby, Danielle Boller, Angelika Eggert, Alexandre Arcaro, Alexander Schramm, Kathrin T. Doepfner, Michael A. Grotzer
Přispěvatelé: University of Zurich, Arcaro, A
Rok vydání: 2008
Předmět:
Zdroj: Clinical Cancer Research. 14:1172-1181
ISSN: 1557-3265
1078-0432
DOI: 10.1158/1078-0432.ccr-07-0737
Popis: Purpose: The phosphoinositide 3-kinase (PI3K)/Akt pathway is frequently activated in human cancer and plays a crucial role in neuroblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K/Akt signaling as a novel antiproliferative approach in neuroblastoma.Experimental Design: The expression pattern and functions of class IA PI3K isoforms were investigated in tumor samples and cell lines. Effects on cell survival and downstream signaling were analyzed following down-regulation of p110α or p110δ in SH-SY5Y and LA-N-1 cells by means of RNA interference.Results: Overexpression of the catalytic p110δ and regulatory p85α isoforms was detected in a panel of primary neuroblastoma samples and cell lines, compared with normal adrenal gland tissue. Although down-regulation of either p110α or p110δ led to impaired cell growth, reduced expression of p110δ also had a selective effect on the survival of SH-SY5Y cells. Decreased levels of p110δ were found to induce apoptosis and lead to lower expression levels of antiapoptotic Bcl-2 family proteins. SH-SY5Y cells with decreased p110δ levels also displayed reduced activation of ribosomal protein S6 kinase in response to stimulation with epidermal growth factor and insulin-like growth factor-I.Conclusions: Together, our data reveal a novel function of p110δ in neuroblastoma growth and survival.
Databáze: OpenAIRE